Myeloid activation clears ascites and reveals IL27-dependent regression of metastatic ovarian cancer
Journal of Experimental Medicine · 2024
DOI: 10.1084/jem.20231967 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2024. Verfasst von Brennah Murphy und 15 weiteren Autor:innen. Beteiligte Einrichtung: Immunology, Microenvironment and Metastasis Program, Ellen and Ronald Caplan Cancer Center, The Wistar Institute , Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Ascites, Interferon-gamma. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: NIAID NIH HHS, W.W. Smith Charitable Trust, NCI NIH HHS.
Abstract (Originalsprache)
Patients with metastatic ovarian cancer (OvCa) have a 5-year survival rate of <30% due to the persisting dissemination of chemoresistant cells in the peritoneal fluid and the immunosuppressive microenvironment in the peritoneal cavity. Here, we report that intraperitoneal administration of β-glucan and IFNγ (BI) induced robust tumor regression in clinically relevant models of metastatic OvCa. BI induced tumor regression by controlling fluid tumor burden and activating localized antitumor immunity. β-glucan alone cleared ascites and eliminated fluid tumor cells by inducing intraperitoneal clotting in the fluid and Dectin-1-Syk–dependent NETosis in the omentum. In omentum tumors, BI expanded a novel subset of immunostimulatory IL27+ macrophages and neutralizing IL27 impaired BI efficacy in vivo. Moreover, BI directly induced IL27 secretion in macrophages where single agent treatment did not. Finally, BI extended mouse survival in a chemoresistant model and significantly improved chemotherapy response in a chemo-sensitive model. In summary, we propose a new therapeutic strategy for the treatment of metastatic OvCa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Immunology, Microenvironment and Metastasis Program, Ellen and Ronald Caplan Cancer Center, The Wistar Institute , Philadelphia, PA, USA.
- Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
- Cancer Biology Graduate Program, Saint Joseph's University, Philadelphia, PA, USA.
- Gene Expression and Regulation Program, Ellen and Ronald Caplan Cancer Center, The Wistar Institute , Philadelphia, PA, USA.
- Medical College of Georgia, Augusta University , Augusta, GA, USA.
- Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
ORCID-Profile: Brennah Murphy, Taito Miyamoto, Bryan S Manning, Gauri Mirji, Alessio Ugolini, Toshitha Kannan, Kohei Hamada, Yanfang P Zhu, Daniel T Claiborne, Lu Huang, Rugang Zhang, Yulia Nefedova, Andrew Kossenkov, Filippo Veglia, Rahul Shinde, Nan Zhang
Förderung
- NIAID NIH HHS
- W.W. Smith Charitable Trust
- NCI NIH HHS
- NINDS NIH HHS
- Japan Society for the Promotion of Science
- NIH HHS
- Department of Defense
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Murphy, B., Miyamoto, T., Manning, B. S., Mirji, G., Ugolini, A., Kannan, T., Hamada, K., Zhu, Y. P., Claiborne, D. T., Huang, L., Zhang, R., Nefedova, Y., Kossenkov, A., Veglia, F., Shinde, R., & Zhang, N. (2024). Myeloid activation clears ascites and reveals IL27-dependent regression of metastatic ovarian cancer. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20231967
Vancouver
Murphy B, Miyamoto T, Manning BS, Mirji G, Ugolini A, Kannan T, et al. Myeloid activation clears ascites and reveals IL27-dependent regression of metastatic ovarian cancer. Journal of Experimental Medicine. 2024. doi:10.1084/jem.20231967
BibTeX
@article{Murphy2024,
author = {Murphy, Brennah and Miyamoto, Taito and Manning, Bryan S and Mirji, Gauri and Ugolini, Alessio and Kannan, Toshitha and Hamada, Kohei and Zhu, Yanfang P and Claiborne, Daniel T and Huang, Lu and Zhang, Rugang and Nefedova, Yulia and Kossenkov, Andrew and Veglia, Filippo and Shinde, Rahul and Zhang, Nan},
title = {Myeloid activation clears ascites and reveals IL27-dependent regression of metastatic ovarian cancer},
journal = {Journal of Experimental Medicine},
year = {2024},
doi = {10.1084/jem.20231967}
}
EUVIMED